| 1 |
30501635 | Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function: effects of Er-NPCs administration. | 2018 Nov 30 |
1 |
| 2 |
28373075 | Recovery from experimental parkinsonism by intrastriatal application of erythropoietin or EPO-releasing neural precursors. | 2017 Jun |
1 |
| 3 |
27789613 | Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice. | 2016 Oct |
1 |
| 4 |
23190369 | A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism. | 2013 Mar |
2 |
| 5 |
19537929 | Increased expression of erythropoietin receptor in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinsonian model. | 2010 |
1 |
| 6 |
16949343 | HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. | 2006 Nov |
1 |
| 7 |
11872260 | Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. | 2002 Mar 15 |
9 |
| 8 |
11163297 | Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. | 2001 Feb 2 |
2 |